Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study
2016 · Annals of Oncology · 52 citations
https://doi.org/10.1093/annonc/mdw157